The report highlights the company's significant value creation for its consumers, customers and shareholders by maximising sales of established products and developing new products that cater to consumer demand and needs. BioGaia's commitment to sustainable development and social responsibility, as evidenced by the company's investment in the Climate Transformation Fund, has helped BioGaia achieve its science-based climate target of a 46% reduction in emissions from 2019. The company also made progress in its efforts to reduce its environmental impact through the use of certified paper from sustainably managed forests and by exploring alternative packaging solutions. BioGaia continues to invest heavily in research and development to expand its product portfolio, discover new bacteria strains and deepen the knowledge of probiotics. The company also made significant progress in its efforts to increase awareness of antibiotic resistance, which is a major threat to human health. The report also highlights the company's commitment to gender equality, with an equal gender distribution in management positions. BioGaia remains on AllBright's green list.
